Syllabus
CMCaP Prep Course (CMCaP)
87 lessons. Online and self-paced.
ECS And Cannabis Science
Foundational science for the endocannabinoid system, phytocannabinoids, minor cannabinoids, terpenes, and product composition. Emphasis is on core mechanisms that support later clinical decision-making.
- 1ECS Components And Enzymes
- 2CB1 Versus CB2 Roles
- 3ECS Homeostasis And Signaling
- 4THC And CBD Pharmacology
- 5Minor Cannabinoids And Terpenes
- 6Ensemble Effect Theory
- 7Chemovars And Product Profiles
- 8Full Spectrum Product Types
- 9Natural Synthetic And Biosynthetic Cannabinoids
- 10Novel Delivery Technologies
- 11Illicit Synthetic Cannabinoid Risks
Pharmacokinetics And Interactions
High-yield pharmacokinetics, pharmacogenomics, detection, and interaction management for cannabis-related therapies. Focus is on route differences, metabolism, and medication safety screening.
- 12Route Specific PK Profiles
- 13First Pass THC Metabolism
- 14Lipophilicity And Tissue Distribution
- 15CYP And Variant Relevance
- 16Personalized Dosing Considerations
- 17Detection Windows And Counseling
- 18CYP Mediated Interaction Patterns
- 19Pharmacodynamic Sedation Risks
- 20Medication Profile Interaction Screen
- 21Interaction Monitoring And Communication
Evidence Based Therapeutics
Critical appraisal and patient-specific application of cannabis evidence across major symptom domains. Emphasis is on quality of evidence, limitations, and role-appropriate recommendations.
- 22Neuropathic And Nociceptive Pain
- 23THC CBD Roles In Pain
- 24Opioid Sparing Evidence Limits
- 25Pain Monitoring And Follow Up
- 26CBD In Seizure Disorders
- 27MS Spasticity And Palliative Care
- 28CINV And Appetite Support
- 29Chemotherapy And Immunotherapy Precautions
- 30Anxiety PTSD And Sleep Data
- 31Psychosis Bipolar And Destabilization
- 32Harm Reduction In Psychiatry
- 33Trial Design And Blinding Challenges
- 34Observational Data And Registries
- 35Marketing Claims Versus Evidence
- 36Patient Specific Evidence Translation
Assessment And Care Planning
Structured pharmacist assessment of eligibility, risk, shared decision-making, and follow-up planning within legal and professional boundaries.
- 37History Medication And Substance Review
- 38Contraindications And High Risk Flags
- 39Qualifying Condition Verification Boundaries
- 40Shared Decision Making Elements
- 41PROMs And Symptom Diaries
- 42Follow Up And Escalation Triggers
Products Dosing And Quality
Practical product selection, route choice, titration strategy, calculations, and quality assurance concepts for pharmacist review.
- 43Inhaled Oral And Topical Forms
- 44Novel Formulation Considerations
- 45Route Selection By Care Goal
- 46Cannabinoid Ratio Selection
- 47Patient Preference And Prior Response
- 48Reputable Source Verification
- 49Start Low Go Slow
- 50Potency Unit Interpretation
- 51Supply Estimation And Dose Checks
- 52Titration Troubleshooting Cases
- 53Certificate Of Analysis Review
- 54Contamination And Quality Risks
- 55Storage And Stability Counseling
Safety And Harm Reduction
Adverse effects, impairment, misuse risk, substance use disorder, and patient-centered counseling for safer cannabis use.
- 56Common THC Adverse Effects
- 57Driving And Safety Counseling
- 58Cannabinoid Hyperemesis Recognition
- 59Adverse Effect Response Plan
- 60Cannabis Use Disorder Criteria
- 61Dependence Tolerance And Addiction
- 62Motivational Interviewing For Risk
- 63Diversion Prevention Strategies
- 64Safe Storage And Handling
- 65Stigma Equity And Communication
- 66Liability And Ethical Boundaries
Communication And Documentation
Interprofessional communication, documentation quality, workflow verification, and safety reporting in cannabis-related pharmacy practice.
- 67Recommendation Framing For Clinicians
- 68Cannabis Subject Matter Communication
- 69Conflict And Disagreement Management
- 70Assessment And Intervention Notes
- 71Minimum Necessary Information Use
- 72Error Near Miss Reporting
- 73Order And Profile Plausibility
- 74Calculation And Conversion Checks
- 75Best Next Step Prioritization
Policy And Professional Practice
Public health, legal conflicts, program compliance, advocacy, and risk management for cannabis pharmacy practice. Emphasis remains on lawful, role-appropriate professional action.
- 76Federal State Conflict Basics
- 77Approved Cannabinoids Versus Cannabis
- 78Role Appropriate Legal Counseling
- 79Program Requirement Verification
- 80PDMP And Controlled Substance Review
- 81Audit Ready Recordkeeping
- 82Community Risk Mitigation
- 83Opioid Harm Reduction Context
- 84Policy Advocacy And Leadership
- 85Professional Liability Risk Control
- 86Continuous Quality Improvement Systems
- 87Recalls Audits And Crisis Plans






